Jpmorgan Chase & CO Cytek Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 598,537 shares of CTKB stock, worth $3.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
598,537
Previous 608,440 1.63%
Holding current value
$3.92 Million
Previous $3.4 Million 2.36%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$4.73 - $6.73 $46,841 - $66,647
-9,903 Reduced 1.63%
598,537 $3.32 Million
Q3 2024

Nov 08, 2024
SELL
$4.73 - $6.73 $46,841 - $66,647
-9,903 Reduced 1.63%
598,537 $3.32 Million
Q2 2024

Dec 26, 2024
BUY
$5.3 - $6.91 $52,485 - $68,429
9,903 Added 1.65%
608,440 $3.4 Million
Q2 2024

Aug 12, 2024
BUY
$5.3 - $6.91 $2.77 Million - $3.61 Million
523,028 Added 612.36%
608,440 $3.4 Million
Q1 2024

Dec 26, 2024
SELL
$6.29 - $9.15 $3.23 Million - $4.7 Million
-513,125 Reduced 85.73%
85,412 $573,000
Q1 2024

May 10, 2024
SELL
$6.29 - $9.15 $391,137 - $568,983
-62,184 Reduced 42.13%
85,412 $573,000
Q4 2023

Dec 26, 2024
SELL
$4.1 - $9.51 $1.85 Million - $4.29 Million
-450,941 Reduced 75.34%
147,596 $1.35 Million
Q4 2023

Feb 12, 2024
BUY
$4.1 - $9.51 $38,527 - $89,365
9,397 Added 6.8%
147,596 $1.35 Million
Q3 2023

Nov 14, 2023
SELL
$5.52 - $9.5 $34,726 - $59,764
-6,291 Reduced 4.35%
138,199 $762,000
Q2 2023

Aug 11, 2023
BUY
$6.69 - $11.99 $366,618 - $657,063
54,801 Added 61.1%
144,490 $1.23 Million
Q1 2023

May 18, 2023
BUY
$8.44 - $13.47 $738,280 - $1.18 Million
87,474 Added 3949.16%
89,689 $824,000
Q1 2023

May 11, 2023
SELL
$8.44 - $13.47 $557,546 - $889,828
-66,060 Reduced 96.76%
2,215 $20,000
Q4 2022

Feb 13, 2023
BUY
$9.71 - $15.86 $48,394 - $79,046
4,984 Added 7.87%
68,275 $697,000
Q3 2022

Nov 14, 2022
BUY
$10.96 - $15.45 $20,133 - $28,381
1,837 Added 2.99%
63,291 $931,000
Q2 2022

Aug 11, 2022
BUY
$7.41 - $11.56 $85,570 - $133,494
11,548 Added 23.14%
61,454 $659,000
Q1 2022

May 11, 2022
BUY
$9.89 - $17.25 $395,342 - $689,551
39,974 Added 402.48%
49,906 $538,000
Q4 2021

Feb 10, 2022
SELL
$16.14 - $25.04 $48,484 - $75,220
-3,004 Reduced 23.22%
9,932 $162,000
Q3 2021

Nov 12, 2021
BUY
$17.52 - $27.93 $226,638 - $361,302
12,936 New
12,936 $277,000

Others Institutions Holding CTKB

# of Institutions
134
Shares Held
71.7M
Call Options Held
400
Put Options Held
0
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $882M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email